Xeris Biopharma Holdings Inc (NASDAQ: XERS) open the trading on Wednesday, with a bit cautious approach as it glided -0.30% to $9.87, before settling in for the price of $9.9 at the close. Taking a more long-term approach, XERS posted a 52-week range of $2.82-$10.02.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 40.01%. Meanwhile, its Annual Earning per share during the time was 40.01%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 94.69%. This publicly-traded company’s shares outstanding now amounts to $161.22 million, simultaneously with a float of $151.50 million. The organization now has a market capitalization sitting at $1.59 billion. At the time of writing, stock’s 50-day Moving Average stood at $8.41, while the 200-day Moving Average is $5.72.
Xeris Biopharma Holdings Inc (XERS) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Xeris Biopharma Holdings Inc’s current insider ownership accounts for 6.18%, in contrast to 56.67% institutional ownership. According to the most recent insider trade that took place on Sep 11 ’25, this organization’s Director sold 15,500 shares at the rate of 7.72, making the entire transaction reach 119,610 in total value, affecting insider ownership by 142,000.
Xeris Biopharma Holdings Inc (XERS) Earnings and Revenue Records
Xeris Biopharma Holdings Inc (NASDAQ: XERS) Trading Performance Indicators
Let’s observe the current performance indicators for Xeris Biopharma Holdings Inc (XERS). It’s Quick Ratio in the last reported quarter now stands at 1.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.48.
In the same vein, XERS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.21, a figure that is expected to reach 0.01 in the next quarter, and analysts are predicting that it will be 0.18 at the market close of one year from today.
Technical Analysis of Xeris Biopharma Holdings Inc (XERS)
[Xeris Biopharma Holdings Inc, XERS] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 84.59% While, its Average True Range was 76.80.
Raw Stochastic average of Xeris Biopharma Holdings Inc (XERS) in the period of the previous 100 days is set at 96.33%, which indicates a major rise in contrast to 81.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.38 that was higher than 0.31 volatility it exhibited in the past 100-days period.
